Sign inGet started

RNAM

Avidity Biosciences, Inc.CIK 1599901 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17

AI insights for RNAM PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for RNAM
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Calderaro Charles IIIChief Technical Officer2$0$02026-02-27
Gallagher Kathleen P.Chief Program Officer10$0$02026-02-27
Skerjanec SimonaDirector3$0$02026-02-27
McCarthy TeresaChief Human Resources Officer8$0$02026-02-27
Flanagan W. MichaelChief Scientific Officer7$0$02026-02-27
Kim Jean JinsunDirector6$0$02026-02-27
Thompson TamarDirector5$0$02026-02-27
Henig NoreenDirector8$0$02026-02-27
Hughes Steven GeorgeChief Medical Officer6$0$02026-02-27
Mosbrooker EricChief Commercial Officer3$0$02026-02-27
Boyce SarahPresident and CEO8$0$02026-02-27
WILSON TROY EDWARDDirector5$0$02026-02-27
Moriarty John BChief Legal Officer3$0$02026-02-27
Kaye Edward M. MDDirector8$0$02026-02-27
MacLean Michael FChief Financial Officer7$0$02026-02-27
BOESS CARSTENDirector7$0$02026-02-27
LEVIN ARTHUR ADirector7$0$02026-02-27

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Calderaro Charles IIIChief Technical Officer D To issuer deriv2026-02-272026-02-2780,000— $00SEC↗
Mosbrooker EricChief Commercial Officer D To issuer deriv2026-02-272026-02-27177,188— $00SEC↗
Mosbrooker EricChief Commercial Officer D To issuer deriv2026-02-272026-02-2750,000— $00SEC↗
BOESS CARSTENDirector D To issuer deriv2026-02-272026-02-2720,858— $00SEC↗
BOESS CARSTENDirector D To issuer deriv2026-02-272026-02-2722,000— $00SEC↗
BOESS CARSTENDirector D To issuer deriv2026-02-272026-02-2713,489— $00SEC↗
BOESS CARSTENDirector D To issuer deriv2026-02-272026-02-2710,034— $00SEC↗
BOESS CARSTENDirector D To issuer deriv2026-02-272026-02-2715,000— $00SEC↗
BOESS CARSTENDirector D To issuer deriv2026-02-272026-02-2722,000— $00SEC↗
Kaye Edward M. MDDirector D To issuer deriv2026-02-272026-02-2713,489— $00SEC↗
Kaye Edward M. MDDirector D To issuer deriv2026-02-272026-02-2710,034— $00SEC↗
Kaye Edward M. MDDirector D To issuer deriv2026-02-272026-02-2722,000— $00SEC↗
Kaye Edward M. MDDirector D To issuer deriv2026-02-272026-02-2722,000— $00SEC↗
Kaye Edward M. MDDirector D To issuer deriv2026-02-272026-02-2715,000— $00SEC↗
Kaye Edward M. MDDirector D To issuer deriv2026-02-272026-02-2711,323— $00SEC↗
Kaye Edward M. MDDirector D To issuer deriv2026-02-272026-02-279,534— $00SEC↗
LEVIN ARTHUR ADirector D To issuer deriv2026-02-272026-02-27115,500— $00SEC↗
LEVIN ARTHUR ADirector D To issuer deriv2026-02-272026-02-27144,000— $00SEC↗
LEVIN ARTHUR ADirector D To issuer deriv2026-02-272026-02-2713,489— $00SEC↗
LEVIN ARTHUR ADirector D To issuer deriv2026-02-272026-02-2710,034— $00SEC↗
LEVIN ARTHUR ADirector D To issuer deriv2026-02-272026-02-2712,500— $00SEC↗
Kim Jean JinsunDirector D To issuer deriv2026-02-272026-02-2722,000— $00SEC↗
Kim Jean JinsunDirector D To issuer deriv2026-02-272026-02-2722,000— $00SEC↗
Kim Jean JinsunDirector D To issuer deriv2026-02-272026-02-2730,000— $00SEC↗
Kim Jean JinsunDirector D To issuer deriv2026-02-272026-02-2713,489— $00SEC↗
Kim Jean JinsunDirector D To issuer deriv2026-02-272026-02-2710,034— $00SEC↗
Henig NoreenDirector D To issuer deriv2026-02-272026-02-2722,000— $00SEC↗
Henig NoreenDirector D To issuer deriv2026-02-272026-02-2711,323— $00SEC↗
Henig NoreenDirector D To issuer deriv2026-02-272026-02-2715,000— $00SEC↗
Henig NoreenDirector D To issuer deriv2026-02-272026-02-279,534— $00SEC↗
Henig NoreenDirector D To issuer deriv2026-02-272026-02-2722,000— $00SEC↗
Henig NoreenDirector D To issuer deriv2026-02-272026-02-2713,489— $00SEC↗
Henig NoreenDirector D To issuer deriv2026-02-272026-02-2710,034— $00SEC↗
Gallagher Kathleen P.Chief Program Officer D To issuer deriv2026-02-272026-02-2727,584— $00SEC↗
Gallagher Kathleen P.Chief Program Officer D To issuer deriv2026-02-272026-02-2716,000— $00SEC↗
Gallagher Kathleen P.Chief Program Officer D To issuer deriv2026-02-272026-02-2713,520— $00SEC↗
Gallagher Kathleen P.Chief Program Officer D To issuer deriv2026-02-272026-02-2742,480— $00SEC↗
Gallagher Kathleen P.Chief Program Officer D To issuer deriv2026-02-272026-02-2750,000— $00SEC↗
Gallagher Kathleen P.Chief Program Officer D To issuer deriv2026-02-272026-02-2713,352— $00SEC↗
Gallagher Kathleen P.Chief Program Officer D To issuer deriv2026-02-272026-02-279,244— $00SEC↗
Gallagher Kathleen P.Chief Program Officer D To issuer deriv2026-02-272026-02-2713,829— $00SEC↗
Gallagher Kathleen P.Chief Program Officer D To issuer deriv2026-02-272026-02-2722,321— $00SEC↗
WILSON TROY EDWARDDirector D To issuer deriv2026-02-272026-02-2713,489— $00SEC↗
WILSON TROY EDWARDDirector D To issuer deriv2026-02-272026-02-2715,000— $00SEC↗
WILSON TROY EDWARDDirector D To issuer deriv2026-02-272026-02-2710,034— $00SEC↗
Flanagan W. MichaelChief Scientific Officer D To issuer deriv2026-02-272026-02-2796,000— $00SEC↗
Flanagan W. MichaelChief Scientific Officer D To issuer deriv2026-02-272026-02-2788,000— $00SEC↗
Flanagan W. MichaelChief Scientific Officer D To issuer deriv2026-02-272026-02-2772,000— $00SEC↗
Flanagan W. MichaelChief Scientific Officer D To issuer deriv2026-02-272026-02-2750,000— $00SEC↗
Flanagan W. MichaelChief Scientific Officer D To issuer deriv2026-02-272026-02-2766,500— $00SEC↗
Flanagan W. MichaelChief Scientific Officer D To issuer deriv2026-02-272026-02-2725,000— $00SEC↗
Moriarty John BChief Legal Officer D To issuer deriv2026-02-272026-02-2750,000— $00SEC↗
Moriarty John BChief Legal Officer D To issuer deriv2026-02-272026-02-27160,000— $00SEC↗
Boyce SarahPresident and CEO D To issuer deriv2026-02-272026-02-27400,000— $00SEC↗
Boyce SarahPresident and CEO D To issuer deriv2026-02-272026-02-27300,000— $00SEC↗
Boyce SarahPresident and CEO D To issuer deriv2026-02-272026-02-27200,000— $00SEC↗
Boyce SarahPresident and CEO D To issuer deriv2026-02-272026-02-27165,000— $00SEC↗
Boyce SarahPresident and CEO D To issuer deriv2026-02-272026-02-27425,000— $00SEC↗
Boyce SarahPresident and CEO D To issuer deriv2026-02-272026-02-27300,000— $00SEC↗
Boyce SarahPresident and CEO D To issuer deriv2026-02-272026-02-27386,015— $00SEC↗
Hughes Steven GeorgeChief Medical Officer D To issuer deriv2026-02-272026-02-2774,000— $00SEC↗
Hughes Steven GeorgeChief Medical Officer D To issuer deriv2026-02-272026-02-2749,333— $00SEC↗
Hughes Steven GeorgeChief Medical Officer D To issuer deriv2026-02-272026-02-2768,458— $00SEC↗
Hughes Steven GeorgeChief Medical Officer D To issuer deriv2026-02-272026-02-2773,342— $00SEC↗
Hughes Steven GeorgeChief Medical Officer D To issuer deriv2026-02-272026-02-2750,000— $00SEC↗
Skerjanec SimonaDirector D To issuer deriv2026-02-272026-02-2742,308— $00SEC↗
Skerjanec SimonaDirector D To issuer deriv2026-02-272026-02-2710,034— $00SEC↗
MacLean Michael FChief Financial Officer D To issuer deriv2026-02-272026-02-2750,000— $00SEC↗
MacLean Michael FChief Financial Officer D To issuer deriv2026-02-272026-02-27106,000— $00SEC↗
MacLean Michael FChief Financial Officer D To issuer deriv2026-02-272026-02-2760,125— $00SEC↗
MacLean Michael FChief Financial Officer D To issuer deriv2026-02-272026-02-27148,000— $00SEC↗
MacLean Michael FChief Financial Officer D To issuer deriv2026-02-272026-02-27131,250— $00SEC↗
MacLean Michael FChief Financial Officer D To issuer deriv2026-02-272026-02-2792,000— $00SEC↗
Thompson TamarDirector D To issuer deriv2026-02-272026-02-2713,489— $00SEC↗
Thompson TamarDirector D To issuer deriv2026-02-272026-02-2710,034— $00SEC↗
Thompson TamarDirector D To issuer deriv2026-02-272026-02-2722,000— $00SEC↗
Thompson TamarDirector D To issuer deriv2026-02-272026-02-2722,000— $00SEC↗
McCarthy TeresaChief Human Resources Office D To issuer deriv2026-02-272026-02-2750,000— $00SEC↗
McCarthy TeresaChief Human Resources Office D To issuer deriv2026-02-272026-02-2778,000— $00SEC↗
McCarthy TeresaChief Human Resources Office D To issuer deriv2026-02-272026-02-2754,000— $00SEC↗
McCarthy TeresaChief Human Resources Office D To issuer deriv2026-02-272026-02-27108,000— $00SEC↗
McCarthy TeresaChief Human Resources Office D To issuer deriv2026-02-272026-02-2757,500— $00SEC↗
McCarthy TeresaChief Human Resources Office D To issuer deriv2026-02-272026-02-2765,000— $00SEC↗
McCarthy TeresaChief Human Resources Office D To issuer deriv2026-02-272026-02-27106,000— $00SEC↗
Calderaro Charles IIIChief Technical Officer D To issuer2026-02-272026-02-2798,547— $00SEC↗
Mosbrooker EricChief Commercial Officer D To issuer2026-02-272026-02-2779,413— $00SEC↗
BOESS CARSTENDirector D To issuer2026-02-272026-02-276,692— $00SEC↗
Kaye Edward M. MDDirector D To issuer2026-02-272026-02-276,692— $00SEC↗
LEVIN ARTHUR ADirector D To issuer2026-02-272026-02-2716,562— $00SEC↗
LEVIN ARTHUR ADirector D To issuer2026-02-272026-02-27131,372— $00SEC↗
Kim Jean JinsunDirector D To issuer2026-02-272026-02-276,692— $00SEC↗
Henig NoreenDirector D To issuer2026-02-272026-02-276,692— $00SEC↗
Gallagher Kathleen P.Chief Program Officer D To issuer2026-02-272026-02-2780,303— $00SEC↗
WILSON TROY EDWARDDirector D To issuer2026-02-272026-02-2713,711— $00SEC↗
WILSON TROY EDWARDDirector D To issuer2026-02-272026-02-2765,091— $00SEC↗
Flanagan W. MichaelChief Scientific Officer D To issuer2026-02-272026-02-27150,365— $00SEC↗
Moriarty John BChief Legal Officer D To issuer2026-02-272026-02-2792,054— $00SEC↗
Boyce SarahPresident and CEO D To issuer2026-02-272026-02-27474,861— $00SEC↗
Hughes Steven GeorgeChief Medical Officer D To issuer2026-02-272026-02-27115,857— $00SEC↗
Skerjanec SimonaDirector D To issuer2026-02-272026-02-276,692— $00SEC↗
MacLean Michael FChief Financial Officer D To issuer2026-02-272026-02-27133,977— $00SEC↗
Thompson TamarDirector D To issuer2026-02-272026-02-276,692— $00SEC↗
McCarthy TeresaChief Human Resources Office D To issuer2026-02-272026-02-27165,296— $00SEC↗